最新公告列表 《配发结果公告》 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 截至2025年12月23日收盘，轻松健康（02661）报收于58.7元，较前一交易日上涨158.82%。该股当日开 盘价为50.0元，盘中最高触及59.8元，最低下探至49.0元，成交额达3.2亿元。其近52周股价区间为49.0 元至59.8元。 近日，公司发布全球发售配发结果公告。公告显示，轻松健康集团（股份代号：2661）全球发售 26,540,000股股份，其中香港公开发售2,654,000股，国际发售23,886,000股，发售价为每股22.68港元。 全球发售所得款项总额约为601.93亿港元，扣除上市开支后净额约513.42亿港元，将用于公司未来计 划。香港公开发售获超额认购1,421.47倍，国际发售认购水平为2.9倍。基石投资者澳琴合鸣获配 4,801,800股，占发售股份18.09%。国际发售无超额分配，稳定价格期间至2026年1月17日结束，期间不 进行稳定价格行动。控股股东及主要股东承诺禁售股份至2026年6月或12月。股份预计于2 ...

Core Insights - The successful IPO of Qingsong Health Group on December 23 marks a significant milestone, with shares opening at HKD 50, a 120% increase from the issue price, and reaching a market capitalization of HKD 11.402 billion [1] - Qingsong Health has transformed from an insurance technology service provider to a comprehensive platform covering health management, medical services, and insurance protection, ranking 10th in the domestic digital health service market [1] - The company is recognized as a pioneer in the "AI + health services + insurance protection" model, capitalizing on the aging population, health consumption upgrades, and ongoing policy benefits [1] Financial Performance - In 2024, Qingsong Health achieved revenue of CNY 945 million, a year-on-year increase of 92.9%, with the first half of 2025 showing revenue of CNY 656 million, up 84.7% [2] - The adjusted net profit has remained above CNY 80 million for three consecutive years from 2022 to 2024, reaching CNY 51.18 million in the first half of 2025, a growth of 11.4% [2] - The revenue share from digital comprehensive health services surged from 15.2% in 2022 to 76.7% in the first half of 2025, with a compound annual growth rate of 221.26% [2] User Base and Retention - As of June 30, 2025, Qingsong Health had 168.4 million registered users, with 60.4% belonging to the core health consumption group aged 20 to 45 [2] - The retention rate for insured users in the 13th month is 92.2%, significantly higher than the industry average, with approximately 46% of policyholders holding two or more insurance products [3] - The conversion rate from active users to policyholders improved from 5.0‰ to 6.7‰ between 2024 and the first half of 2025 [3] AI Integration and Technology - Qingsong Health's self-developed AIcare technology stack is integrated across the entire business chain, enhancing areas such as content creation, intelligent underwriting, risk prediction, claims review, and health management [4] - The Galaxy AI marketing platform generated 12.9 million high-quality business leads by 2025, with AI-driven leads accounting for 21.3% of new policies in a complex market environment [5] - The company launched the generative AI tool "Qingsong Ask Doctor Dr.GPT" in 2023, providing 24/7 professional health consultations and assisting doctors in preliminary diagnoses [5] Industry Outlook - The digital health industry in China is entering a golden development period, with the comprehensive health services and health insurance market projected to reach CNY 11.8 trillion by 2029, growing at a compound annual growth rate of 7.7% from 2024 to 2029 [6] - Qingsong Health plans to utilize funds raised from its IPO to enhance AI technology, extend health service scenarios, and integrate the industry chain, aiming to strengthen its ecosystem [6] - The company is positioned to align with the "Healthy China" strategy, with strong growth potential, making it a core investment target in the Hong Kong digital health sector [6]

具体来看，公司以自主研发的AIcare 技术体系为核心，将AI能力应用于健康内容生成、风险评估、智 能承保、理赔审核及用户运营等关键场景，显著提升服务效率与转化能力。在此基础上，轻松健康构建 起覆盖"检、医、药、康、险"的全链条数字健康服务生态，实现健康管理与保险保障的深度融合。这一 模式被市场视为AI在健康产业中实现规模化、可持续落地的重要创新方向。 12月23日，轻松健康集团正式登陆港交所主板，上市首日股价表现强劲。开盘即高开后持续走强，盘中 一度拉升至近60港元，收盘58.7港元，较发行价上涨近160%，成交持续放量，成为当日港股市场资金 关注度较高的新股之一。 在上市前阶段，公司已显现出明显的资本热度。招股期间，轻松健康集团公开发售部分获得投资者踊跃 参与，认购倍数超1400倍，显示出一级市场对其商业模式与成长空间的高度认可。上市前一日的暗盘交 易中，股价同样表现亮眼，暗盘收盘涨幅超130%，资金热情在正式挂牌前已提前释放。 市场分析认为，轻松健康上市首日的强劲走势，并非单纯情绪推动，而是资本对"AI+健康"重大创新路 径的集中定价。与传统健康平台或单一保险科技公司不同，轻松健康通过人工智能技术深度嵌 ...

Core Viewpoint - The Hong Kong IPO market remains vibrant as the digital health service platform, Easy Health Group, successfully debuted, reflecting strong market confidence and potential for long-term investment value [1][2]. Group 1: IPO Performance - Easy Health Group officially listed on the Hong Kong main board on December 23, with its stock price surging over 163% at one point, closing with a gain of 158.82%, resulting in a market capitalization exceeding HKD 12.1 billion [2]. - The company’s IPO was highly anticipated, with a global subscription oversubscription rate of 1421 times, indicating strong investor interest and confidence in its future growth [2][3]. - The company plans to issue approximately 26.54 million shares, with a public offering price set at HKD 22.68 per share, reflecting a robust market response [2]. Group 2: Business Transformation and Financial Performance - Easy Health Group has successfully transitioned to a comprehensive health service model, with a reported revenue of HKD 945 million in 2024, representing a year-on-year growth of 92.9% [4]. - For the first half of 2025, revenue further increased to HKD 656 million, marking an 84.7% year-on-year growth, significantly outpacing industry averages [4]. - The company ranks 10th in the domestic digital health service and health insurance market, and 7th in the digital health service sector, indicating a solid industry position [4]. Group 3: Business Model and Ecosystem - The dual-driven model of "health services + insurance technology" has established a comprehensive ecosystem, allowing users to access a full range of services from health monitoring to insurance claims [6]. - The health service segment has become the core growth engine, with a compound annual growth rate of 221.26% over the past three years, and its revenue share reaching 76.7% in the first half of 2025 [5]. - The company collaborates with 58 insurance companies, offering 294 insurance products, leveraging AI for improved marketing and risk control efficiency [5][6]. Group 4: Technological Advancements - Easy Health Group has registered 58 invention patents and 39 software copyrights, with significant investments in R&D, totaling approximately HKD 186 million over the past three years [7]. - The AI Care 4.0 service system empowers various health management and insurance service scenarios, enhancing operational efficiency and user experience [7][8]. - The Galaxy AI marketing platform has generated 12.9 million business leads, with the value contribution of AI models increasing from 1.5% in 2022 to 23.3% in 2024, demonstrating the effectiveness of AI in driving business growth [8]. Group 5: Market Potential and User Engagement - The platform has registered 168.4 million users, with 60.4% belonging to the core health consumer demographic aged 20-45, indicating a strong market base for health services [10]. - The company boasts a high user retention rate of 92.2% after 13 months, reflecting the platform's strong appeal and service quality [10]. - The ongoing growth in user conversion rates and insurance uptake highlights the effectiveness of the company's AI-driven marketing and product matching capabilities [11]. Group 6: Future Outlook - The digital health market in China is still in a growth phase, with increasing demand for comprehensive health management services, providing ample opportunities for expansion [11]. - Continuous advancements in AI technology and the deepening of the ecosystem will further differentiate the company from competitors and enhance its service offerings [11]. - Easy Health Group's successful business transformation and technological foundation position it well to capitalize on industry trends and drive future growth [11].

Core Viewpoint - The Hong Kong IPO market remains vibrant as the digital health service platform, Easy Health Group, successfully listed, reflecting strong market confidence and potential for long-term investment returns [1][2]. Group 1: IPO Performance - Easy Health Group officially listed on the Hong Kong main board on December 23, with a first-day closing price of HKD 58.7, marking a 158.82% increase from its IPO price of HKD 22.68 [2]. - The company achieved a global subscription oversubscription rate of 1421 times, indicating high investor interest and confidence in its future growth [2][3]. - The strong performance on the first trading day was supported by a pre-listing dark market trading surge of over 127% [2]. Group 2: Business Transformation and Financial Performance - Easy Health Group has successfully transitioned to a comprehensive health service model, with revenue reaching HKD 945 million in 2024, a year-on-year increase of 92.9% [4]. - For the first half of 2025, revenue further increased to HKD 656 million, reflecting an 84.7% year-on-year growth, significantly outpacing industry averages [4]. - The company ranks 10th in the domestic digital health service and health insurance market, and 7th in the digital health service market, indicating a solid industry position [4]. Group 3: Business Model and Ecosystem - The dual-driven model of "health services + insurance technology" has established a comprehensive ecosystem, allowing users to access a full range of services from health monitoring to insurance claims [6]. - The health service business has become the core growth engine, with a compound annual growth rate of 221.26% over the past three years, and its revenue share reached 76.7% in the first half of 2025 [5]. - The integration of AI technology enhances operational efficiency and customer acquisition, creating a unique service barrier and further collaboration between health services and insurance [8][9]. Group 4: Technological Advancements - Easy Health Group has registered 58 invention patents and 39 software copyrights, demonstrating its commitment to technological innovation [7]. - The AI Care 4.0 system empowers various core scenarios in health management and insurance services, showcasing the company's technological capabilities [7]. - The AI marketing platform has generated 12.9 million business leads, with the value contribution from AI models increasing from 1.5% in 2022 to 23.3% in 2024, highlighting the effectiveness of AI in enhancing business performance [8]. Group 5: Market Potential and User Engagement - The platform has registered 168.4 million users, with 60.4% belonging to the core health consumer group aged 20-45, indicating a strong user base for business monetization [10]. - The company boasts a high user retention rate of 92.2% after 13 months, reflecting the platform's strong appeal [10]. - The ongoing growth in user conversion rates and insurance uptake demonstrates the effectiveness of the company's AI-driven marketing and product matching capabilities [11].

Core Viewpoint - The successful listing of Easy Health Group on the Hong Kong Stock Exchange reflects strong market confidence in the digital health sector and the company's robust fundamentals, with the stock opening at HKD 50, a 120% increase from the issue price [1] User Base - The platform has accumulated 168.4 million registered users, with 60.4% of them being the core health consumer group aged 20-45, providing a solid foundation for revenue growth [1] Technology - The self-developed AIcare technology stack is widely applied in key areas such as content creation, smart underwriting, and claims review, with the value contribution from AI models continuously improving, demonstrating significant technological empowerment [1] Financial Performance - The company expects a revenue growth of 92.9% year-on-year to HKD 945 million in 2024, with a further increase of 84.7% to HKD 656 million in the first half of 2025, and health service revenue now accounts for 76.7% of total income, becoming the main growth engine [1] Market Position - In the context of increasing differentiation in the Hong Kong IPO market and the high demand for scarce assets, Easy Health Group's unique advantages of "AI technology + user scale + business closure" have successfully attracted investor attention, laying a foundation for future stock performance [1] Strategic Alignment - The company operates in a sector that aligns with the "Healthy China" strategy, indicating strong growth certainty and the potential to become a core asset in the Hong Kong digital health sector [1]

Core Viewpoint - The Hong Kong stock market has seen significant gains, with several companies experiencing substantial increases in their stock prices, indicating a bullish trend in the market. Group 1: Top Gainers - Nobikang (02635.HK) has surged by 336.25%, reaching a price of 349.00 [1][2] - Relax Health (02661.HK) has increased by 156.39%, with a latest price of 58.15 [1][2] - New Idea Group (08412.HK) has risen by 27.78%, now priced at 0.46 [1][2] - Star Kai Holdings (01166.HK) has gained 25.86%, with a current price of 0.73 [1][2] - He Feng Group (02320.HK) has seen a rise of 25.71%, priced at 0.0886 [1][2] - Asia Express (08620.HK) has increased by 25.61%, now at 0.10 [1][2] - Chuanghui Jewelry (08537.HK) has grown by 20.97%, with a price of 0.30 [1][2] - Port Robot (00370.HK) has risen by 17.33%, priced at 0.88 [1][2] - Yijun Group Holdings (02442.HK) has increased by 17.09%, now at 12.06 [1][2] - Fengzhan Holdings (01826.HK) has gained 15.85%, with a latest price of 0.095 [1][2]

Core Viewpoint - The listing of Qingsong Health Group on the Hong Kong Stock Exchange marks the beginning of its international capital journey and validates the commercial value of its "AI + health services + insurance" closed-loop model, injecting new momentum into China's rapidly growing digital health industry [1][9]. Group 1: Company Overview - Qingsong Health Group, established in 2014, has successfully transformed from an insurance technology service provider to a comprehensive digital health platform integrating health management, insurance technology, and medical services [3]. - The company ranks 10th in the domestic digital comprehensive health services and health insurance market, and 7th in the digital health services market as of 2024 [3]. Group 2: Financial Performance - Qingsong Health Group has shown steady revenue growth and continuous optimization of its business structure, with a 92.9% year-on-year revenue increase to 945 million yuan in 2024, and a 140% increase compared to 2022 [4]. - The company’s revenue for the first half of 2025 is projected to reach 656 million yuan, reflecting an 84.7% year-on-year growth [4]. - Adjusted net profit has remained above 80 million yuan for three consecutive years from 2022 to 2024, reaching 51.18 million yuan in the first half of 2025, a year-on-year increase of 11.4% [4]. Group 3: Business Structure and Growth Drivers - The company has successfully transitioned from an "insurance-led" model to one led by "health services," with the revenue share of digital comprehensive health services rising from 15.2% in 2022 to 76.7% in the first half of 2025, achieving a compound annual growth rate of 221.26% over three years [5]. - The health services segment includes various offerings such as health content education, digital medical research assistance, comprehensive health service packages, and early disease screening promotion and consultation [5]. - The insurance technology business has also developed steadily, collaborating with 58 insurance companies to launch 294 health insurance products, with insurance technology service revenue reaching 99.44 million yuan in the first half of 2025 [5]. Group 4: User Base and Engagement - As of June 2025, Qingsong Health Group has accumulated 168.4 million registered users, with 60.4% belonging to the core health consumer group aged 20-45, indicating significant potential for health service and insurance demand [7]. - The company boasts a high user retention rate of 92.2% after 13 months, significantly exceeding the industry average, and has shown improved conversion efficiency with a purchase conversion rate rising from 5.0‰ to 6.7‰ [7]. Group 5: AI Integration and Ecosystem Development - Qingsong Health Group's core competitiveness stems from the deep integration of AI technology with business scenarios, utilizing its self-developed AIcare technology stack across various core applications [8]. - The contribution of AI models to annualized premium value has increased from 1.5% in 2022 to 23.3% in 2024, remaining at 21.3% in the first half of 2025, highlighting its role as a key growth driver [8]. - The company has launched innovative AI tools such as "Dr.GPT" for intelligent consultation and personalized health management, enhancing service efficiency for both users and healthcare providers [8]. Group 6: Market Opportunities and Future Outlook - The listing of Qingsong Health Group coincides with a golden period for China's digital health industry, supported by increasing health awareness and favorable policies [9]. - The market for comprehensive health services and health insurance in China is projected to reach 11.8 trillion yuan by 2029, with a compound annual growth rate of 7.7% from 2024 to 2029, indicating vast market potential [9]. - The company plans to utilize the funds raised from its IPO to enhance AI technology, extend health service scenarios, and integrate industry resources, aiming to strengthen its ecosystem and explore new markets [10].

Core Insights - The health technology sector is entering a phase of ecological integration, driven by the upgrade of consumer health demands and deep penetration of AI technology, accelerating the industry's transition from fragmented services to an integrated ecosystem [1] Group 1: Market Dynamics - On December 23, 2023, Easy Health Group successfully listed on the Hong Kong Stock Exchange with an offer price of HKD 22.68 per share, receiving a subscription rate of 1421.47 times for public offerings and 2.9 times for international placements [2] - The company's stock opened at a 120.46% increase on its first trading day, closing at HKD 55.25, representing a 143.61% rise and a market capitalization of HKD 11.402 billion [2][3] Group 2: Business Model and Growth - Easy Health Group has a solid foundation with 168.4 million registered users and leverages AI technology to create a fusion ecosystem of health services and insurance technology, achieving nearly doubled revenue growth [5] - The company provides comprehensive health solutions, addressing user needs from prevention to intervention, and has organized 1,448 early disease screening activities in 2024 [7] - The revenue from full-cycle health management services surged from 15.2% in 2022 to 76.7% in the first half of 2025, with digital marketing becoming a major growth driver [12] Group 3: User Engagement and Retention - The user base is primarily composed of individuals aged 20 to 45, with 60.4% belonging to this core demographic, which is crucial for driving health consumption upgrades [15] - The company has achieved a 92.2% retention rate for policyholders after 13 months, significantly higher than the industry average, indicating effective user engagement strategies [16] Group 4: Technological Innovation - AI technology is a core engine for growth, with Easy Health Group developing a comprehensive AIcare technology stack that enhances service efficiency and user engagement [20][21] - The company has filed for 58 patents and 39 software copyrights, strengthening its technological barriers [22] Group 5: Market Potential - The digital health market in China is projected to grow significantly, with the penetration rate expected to rise from 2.8% in 2024 to 7.1% by 2029, and the market size for digital comprehensive health services and health insurance projected to increase from CNY 236.5 billion to CNY 748.5 billion [25][27] - Easy Health Group's extensive user health data provides ample resources for AI model training, optimizing technology to enhance service efficiency and user stickiness, thereby attracting more partners and users [27] Group 6: Conclusion - The listing of Easy Health Group on the Hong Kong Stock Exchange marks a significant milestone in its development and signals the capital market's recognition of the health technology integration model [29]

12月23日消息，港股三大指数涨跌不一。截至午间收盘，恒生指数涨0.18%，报25848.99点，恒生科技 指数跌0.42%，国企指数涨0.11%。盘面上，科网股涨跌不一，京东、联想涨近1%，快手跌超3%，小 米、腾讯跌超1%；风电股涨幅居前，东方电气涨超5%；黄金股延续涨势，山东黄金涨超5%；锂电池板 块涨幅居前，赣锋锂业涨超4%；今日翰思艾泰、轻松健康、诺比侃上市 | 代码 | 名称 | | 最新价 涨跌幅 > | | | --- | --- | --- | --- | --- | | 01072 | 东方电气 | 0 | 25.260 5.34% | | | 00658 | 中国高速传动 | | 1.500 1.35% | | | 00579 | 京能清洁能源 | | 2.360 | 1.29% | | 00916 | 龙源电力 | | 6.770 1.20% | | | 02208 | 全风科技 | | 13.910 0.72% | | 黄金股延续涨势，山东黄金涨超5%。亚洲早盘，现货黄金涨超1%，最高至4490.88美元/盎司，续创历 史新高。摩根大通指出，关税不确定性，叠加ETF与各国央行的强劲需 ...